adenoviru
ad
base
vaccin
consid
cancer
immunotherapi
yet
detail
knowledg
mechan
action
optim
deliveri
rout
antitumor
efficaci
lack
compar
antitumor
efficaci
adbas
melanoma
vaccin
intraderm
intraven
intranas
intraperiton
deliveri
melanoma
model
intraderm
rout
induc
superior
system
antimelanoma
immun
signalingdepend
predomin
transduct
nonprofession
antigenpres
cell
dermal
vaccin
site
drain
lymph
node
suggest
role
crosspresent
confirm
vitro
conclud
dermi
provid
optim
rout
entri
adbas
vaccin
highefficaci
system
antitumor
immun
immun
like
involv
crossprim
event
drain
lymph
node
metastat
melanoma
aggress
type
skin
cancer
surgic
intervent
prior
metastasi
remain
cur
therapi
option
novel
therapeut
strategi
therefor
urgent
identif
molecular
character
melanoma
antigen
recogn
cellular
compon
adapt
immun
system
pave
way
develop
viral
vector
base
genet
immun
adenoviru
type
vector
commonli
use
vector
gene
deliveri
sinc
viru
exhibit
rel
low
cytotox
high
clone
replic
capac
abil
infect
divid
nondivid
preclin
evalu
base
melanoma
vaccin
includ
recombin
encod
either
murin
human
tyrosinaserel
protein
trp
tyrosinaserel
protein
melanosom
enzym
endogen
express
melanocyt
melanoma
perricon
et
al
report
administr
adenoviru
type
vector
encod
murin
two
intraderm
site
inhibit
subsequ
subcutan
tumor
growth
contradict
studi
conduct
vector
vaccin
mice
encod
autolog
fulllength
induc
effect
specif
cellular
immun
respons
result
erad
melanoma
tumor
howev
vaccin
mice
via
intraperiton
ip
rout
encod
xenogen
human
murin
immunodomin
epitop
fuse
green
fluoresc
protein
gfp
contain
immunogen
foreign
helper
sequenc
abl
overcom
peripher
toler
induc
effect
specif
cell
via
cell
depend
thu
induc
specif
immun
respons
complet
prevent
outgrowth
lung
metastas
subcutan
growth
melanoma
whether
due
rout
immunizationdepend
induct
compartment
antigen
specif
cellular
immun
respons
yet
evalu
identif
optim
rout
administr
base
melanoma
vaccin
induc
system
immun
respons
may
prove
particularli
import
order
erad
metastat
tumor
grow
distinct
tissu
bodi
eg
skin
lung
brain
viscer
tissu
present
studi
evalu
effect
administr
rout
specif
cell
prime
efficaci
abil
prime
effector
cell
erad
tumor
grow
differ
site
bodi
ie
subcutan
sc
vs
lung
administr
rout
compar
ip
intraven
iv
intranas
intraderm
id
latter
prove
effect
induc
potent
system
cell
immun
result
complet
prevent
melanoma
outgrowth
subcuti
well
lung
critic
factor
induc
immun
respons
self
antigen
effici
deliveri
vaccin
profession
antigen
present
cell
apc
ie
dendrit
cell
dc
skin
contain
epiderm
langerhan
cell
lc
dermal
dc
skindrain
ln
contain
resid
skinderiv
dc
popul
classic
paradigm
skin
dc
recogn
key
apc
capabl
prime
naiv
cell
contrast
ln
resid
dc
rather
skin
dc
report
key
apc
prime
cell
respons
antigen
encod
vaccinia
viru
herp
simplex
viru
hsv
influenza
virus
howev
role
skinderiv
dc
adinduc
cell
respons
report
led
us
investig
possibl
role
skin
dc
induct
cell
respons
addit
investig
involv
signal
event
innat
immun
respons
mediat
tolllik
receptor
tlr
mammalian
tlr
famili
highli
conserv
germlineencod
transmembran
receptor
recogn
conserv
microbi
product
pathogenassoci
molecular
pattern
pamp
detect
pamp
tlr
recruit
distinct
set
adapt
molecul
turn
activ
specif
downstream
signal
molecul
lead
induct
immun
respons
elimin
invad
tlr
signal
four
adaptor
identifi
myeloid
differenti
factor
key
adaptor
tlrdepend
inflammatori
signal
pathway
well
signal
interact
varieti
cellular
protein
lead
activ
jnk
mapkinas
induct
inflammatori
cytokin
chemokin
type
key
role
induc
proinflammatori
cytokin
secret
activ
dc
antigen
specif
adapt
immun
respons
previous
present
evid
suggest
id
vaccin
efficaci
crossprim
depend
requir
skinderiv
dc
dcbase
signal
fiveto
tenweek
old
wildtyp
mice
b
purchas
harlan
netherland
ko
mice
b
background
kindli
provid
dr
akira
osaka
univers
japan
mice
hous
individu
ventil
cage
filter
top
experiment
anim
facil
vu
univers
medic
center
amsterdam
netherland
anim
experi
carri
follow
eu
nation
guidelin
approv
institut
scientif
ethic
review
committe
b
spontan
murin
melanoma
cell
line
maintain
dmem
biowhittak
vervier
belgium
supplement
heat
inactiv
fetal
calf
serum
ieml
sodium
penicillin
streptomycin
sulphat
l
glutamin
mm
mous
embryon
fibroblast
cell
line
also
cultur
dmem
supplement
heat
inactiv
normal
calf
serum
instead
fetal
calf
serum
b
bind
peptid
svydffvwl
deriv
murin
melanosom
protein
tyrosinaserel
protein
b
bind
peptid
icpmyarv
deriv
escherichia
coli
purchas
peptid
synthesi
facil
leiden
univers
medic
centr
leiden
netherland
peptid
dissolv
concentr
pb
contain
dmso
store
use
replic
defect
region
delet
adenoviru
vector
encod
enhanc
green
fluoresc
protein
egfp
egfp
singl
b
bind
peptid
epitop
control
cytomegaloviru
promot
use
studi
vector
propag
cell
purifi
ultracentrifug
caesium
chlorid
gradient
vector
titr
determin
use
standard
protocol
rapid
titrat
kit
clontech
lab
inc
mountainview
ca
usa
store
frozen
use
mice
vaccin
twice
day
infecti
unit
iu
vector
resuspend
steril
phosphat
buffer
salin
pb
use
microfin
insulin
syring
needl
bd
bioscienc
franklin
lake
nj
usa
interderm
id
flank
skin
intraven
iv
tail
vein
intraperiton
ip
rout
pipett
filter
tip
greiner
bioon
germani
use
deliveri
vector
intranas
rout
experi
vaccin
site
excis
perform
post
id
vaccin
use
steril
scissor
excis
wound
close
use
surgic
stapl
glue
nederland
bv
leiden
netherland
mice
inject
either
pb
iumic
via
id
administr
flank
skin
evalu
vivo
dc
transduct
effici
skin
site
inject
pb
respect
inject
site
drain
lymph
node
ln
axillari
harvest
post
inject
analyz
immunofluoresc
stain
mice
implant
either
sc
sc
tumor
model
iv
tail
vein
lung
metastasi
model
syngen
cell
resuspend
pb
respect
sc
tumor
diamet
monitor
use
digit
slide
callip
everi
day
end
experi
report
tumor
volum
calcul
use
formula
ab
larger
diamet
b
smaller
diamet
mice
iv
administ
tumor
cell
sacrif
day
postinocul
overdos
anaesthesia
lung
collect
bleach
feket
solut
subsequ
fix
day
formaldehyd
fixat
lobe
dissect
digit
photograph
number
surfac
metastas
count
use
adob
photoshop
softwar
peor
fitclabel
mab
direct
iaie
murin
fitclabel
mab
direct
murin
bd
bioscienc
franklin
lake
nj
usa
use
determin
frequenc
dc
cell
recogn
peptid
produc
flow
cytometr
analysi
intracellular
stain
antigenspecif
cell
analysi
perform
stain
splenocyt
allophycocyanin
apc
label
b
tetram
load
peptid
svydffvwl
sanquin
amsterdam
netherland
antibodi
tetram
stain
perform
pb
supplement
bsa
sodiumazid
min
min
respect
cell
counterstain
pharmingen
analys
use
facscalibur
bd
bioscienc
franklin
lake
nj
usa
addit
sampl
stain
propidium
iodid
icn
biomed
zoeterm
netherland
dead
cell
exclus
within
cell
popul
percentag
tetramerposit
cell
determin
gate
forward
scatter
exclus
propidioum
idodid
posit
cell
use
cellquest
pro
analysi
softwar
bd
bioscienc
franklin
lake
nj
usa
intracellular
stain
ic
assay
carri
describ
previous
elia
et
al
minor
modif
use
intracellular
stain
kit
bd
bioscienc
franklin
lake
nj
usa
briefli
two
three
million
mous
pbmc
splenocyt
stimul
either
concentr
h
presenc
golgiplug
bd
bioscienc
franklin
lake
nj
usa
cell
wash
stain
antibodi
fix
permeabil
incub
fitc
conjug
antimous
mab
bd
bioscienc
franklin
lake
nj
usa
cell
analyz
facscalibur
flow
cytomet
use
cellquest
pro
softwar
bd
bioscienc
franklin
lake
nj
usa
skin
biopsi
site
vaccin
vaccin
site
drain
ln
axillari
identifi
inject
evan
blue
dye
sigma
st
loui
mo
remov
fix
paraformaldehyd
sucros
pb
min
fix
tissu
embed
tissuetec
oct
sakura
fineteck
zoeterwoud
netherland
liquid
nitrogen
cut
frozen
tissu
block
mount
polyllysineco
slide
slide
dri
room
temperatur
rt
overnight
fix
cold
aceton
min
store
use
slide
brought
rt
place
pb
remov
oct
endogen
biotin
block
dako
corpor
carpinteria
ca
usa
slide
stain
biotinyl
antiiai
mab
bd
pharmingen
san
diego
ca
usa
specif
bind
antibodi
detect
use
streptavidin
invitrogen
carlsbad
ca
usa
dapi
molecular
probe
eugen
usa
use
stain
nuclei
slide
mount
use
mount
medium
immunoconcept
na
ltd
sacramento
ca
usa
stain
evalu
fluoresc
microscopi
nikon
instrument
bv
amstelveen
netherland
use
appropri
filter
bone
marrowderiv
dc
bmdc
gener
bmc
wt
ko
mice
describ
samsom
et
al
directli
transduc
vector
encod
transgen
express
dc
plate
round
bottom
well
plate
greiner
bioon
splenocyt
contain
cell
isol
mice
vaccin
ad
vector
encod
epitop
ratio
overnight
stimul
percentag
cell
produc
intracellular
determin
flow
cytometri
describ
determin
crosspresent
capac
bmdc
wt
vs
ko
mice
hla
mismatch
murin
embryon
fibroblast
cell
line
background
infect
encod
infect
express
cell
harvest
wash
extens
coincub
bmdc
wt
ko
mice
ratio
anoth
subsequ
bmdc
harvest
use
stimul
specif
describ
data
analyz
use
one
way
anova
bonferroni
correct
use
graphpad
prism
softwar
previou
studi
report
ip
rout
deliveri
vaccin
induc
strongest
cell
respons
epitop
deriv
exogen
antigen
ovalbumin
ova
compar
administr
rout
evalu
optim
deliveri
rout
vaccin
induc
effect
system
cell
respons
melanomaspecif
self
antigen
made
headtohead
comparison
antigen
specif
cell
level
pbl
day
postvaccin
splenocyt
day
postvaccin
mice
vaccin
via
id
iv
ip
rout
measur
specif
immun
respons
ic
analysi
carri
pbl
splenocyt
restimul
vitro
b
bind
peptid
addit
tetram
tm
use
quantifi
specif
cell
level
splenocyt
id
rout
vaccin
induc
strongest
well
long
last
least
day
postvaccin
specif
cell
respons
determin
frequenc
produc
cell
tm
analysi
pbl
splenocyt
fig
detect
lower
respons
achiev
ip
iv
rout
vaccin
wherea
reactiv
detect
upon
vaccin
fig
note
iv
rout
vaccin
appear
induc
cell
impair
cytokin
product
specif
tcell
frequenc
measur
splenocty
use
tm
correl
specif
cell
frequenc
determin
use
ic
analysi
day
postvaccin
fig
accord
observ
higher
cell
rate
id
vaccin
induc
local
coat
depigment
vaccin
site
well
site
sc
tumor
inocul
fig
indic
effect
break
toler
autoimmun
mediat
destruct
melanocyt
previou
studi
report
effect
differ
rout
applic
antigenpuls
dc
vaccin
ad
vector
encod
exogen
model
antigen
antitumor
efficaci
investig
whether
rout
applic
also
affect
antitumor
efficaci
vaccin
use
subcutan
melanoma
model
id
rout
applic
complet
iv
rout
applic
partial
protect
mice
subcutan
growth
melanoma
wherea
rout
applic
show
signific
antitumor
efficaci
fig
also
evalu
antitumor
efficaci
id
iv
vaccin
rout
use
lung
metastasi
model
data
shown
fig
reveal
id
iv
vaccin
protect
mice
outgrowth
lung
metastas
similar
degre
note
protect
accompani
system
induct
strong
longlast
cell
respons
detect
blood
upto
day
postvaccin
fig
potent
specif
cell
respons
induc
id
administr
prompt
us
determin
whether
effici
deliv
transgen
dc
flank
skin
auxiliari
drain
ln
assess
gfp
express
dc
day
id
inject
skin
dc
identifi
mhcii
express
dc
drain
ln
identifi
express
transduc
fig
gfp
express
observ
mhcii
neg
skinand
lnresid
cell
base
local
deep
dermi
ln
sinus
fig
morpholog
like
fibroblast
suggest
induc
cell
respons
result
crosspresent
dc
corrobor
ex
vivo
infect
skin
ln
suspens
infect
flow
cytometr
analysi
reveal
gfp
express
mhcii
dc
data
shown
studi
import
skinderiv
cell
specif
immun
induct
vector
dermal
vaccin
site
surgic
excis
post
vaccin
data
show
surgic
intervent
significantli
reduc
cell
rate
fig
affect
antitumor
efficaci
fig
ko
mice
use
evalu
role
critic
tlr
adapt
gene
induct
specif
cell
respons
obtain
data
reveal
cell
frequenc
significantli
lower
pbl
ko
mice
compar
wt
mice
day
postvaccin
dayspost
vaccin
splenocyt
fig
similarli
signal
requir
complet
protect
outgrowth
sc
tumor
observ
upon
id
vaccin
fig
tlrmediat
activ
profession
apc
ie
dc
gener
regard
essenti
induct
effect
cellmedi
immun
investig
requir
dc
cell
cross
prime
vitro
studi
reveal
dc
abl
present
crosspres
transgen
epitop
cell
induc
antigenspecif
product
effici
compet
wt
dc
fig
present
studi
show
rout
administr
melanoma
vaccin
determin
magnitud
induc
melanoma
specif
cell
respons
control
local
tumor
outgrowth
signific
select
rout
vaccin
administr
induct
system
antitumor
ctl
immun
thoroughli
investig
use
dc
base
cancer
vaccin
mullin
et
al
show
rout
administr
dc
base
vaccin
determin
locat
primari
cell
activ
distribut
memori
cell
control
local
tumor
outgrowth
recent
impact
vector
immun
via
differ
rout
biodistribut
vector
also
impact
induct
antigen
specif
ctl
respons
studi
use
encod
nonself
model
antigen
chicken
ovalbumin
ova
first
studi
reveal
ip
rout
administr
effect
induc
ova
specif
cell
respons
wherea
sc
rout
prove
potent
latter
studi
howev
neither
studi
evalu
antitumor
efficaci
induc
immun
respons
studi
biodistribut
vector
administ
via
differ
rout
reveal
id
rout
administr
transgen
deliv
vaccin
site
reach
local
drain
ln
iv
rout
transgen
reach
liver
spleen
ln
organ
ip
rout
drain
ln
spleen
rout
lung
brain
drain
ln
data
suggest
wider
distribut
achiev
ip
iv
rout
administr
facilit
widespread
system
immun
respons
permit
id
rout
howev
clearli
found
id
rout
vaccin
induc
potent
system
antitumor
cell
respons
compar
rout
vaccin
probabl
due
presenc
vast
network
suscept
fibroblast
murin
skin
readi
access
high
number
dc
skin
drain
ln
compar
id
sc
rout
administr
howev
believ
slight
modif
depth
inject
could
significantli
hamper
efficaci
vaccin
due
absenc
dc
access
lymphat
vessel
sc
layer
consid
therefor
vital
virus
deliv
id
even
though
vector
report
effect
deliv
transgen
mucos
tissu
due
natur
tropism
mucos
epithelia
fail
detect
transgenespecif
cell
respons
either
peripher
blood
spleen
upon
deliveri
research
need
establish
whether
due
differ
tissu
home
abil
specif
cell
prime
mucosadrain
ln
previous
report
dc
base
vaccin
altern
mucos
surfac
target
deliveri
may
suffici
conduc
gener
effect
cellmedi
antitumor
immun
rather
lead
humor
immun
absenc
proper
danger
signal
even
lead
toler
induct
skin
sensit
immun
organ
due
presenc
dens
network
profession
apc
ie
langerhan
cell
lc
demal
dc
henc
form
attract
site
vaccin
dc
capabl
break
peripher
toler
initi
adapt
immun
respons
self
antigen
tumor
antigen
self
antigen
consider
peripher
toler
maintain
target
deliveri
tumor
antigen
dc
consid
promis
immunotherapeut
approach
overcom
peripher
toler
promot
antitumor
immun
respons
although
vector
consid
tumor
vaccin
vehicl
effici
infect
dc
vitro
nevertheless
id
vaccin
induc
potent
antitumor
immun
respons
mice
therefor
decid
investig
whether
employ
vector
deliv
transgen
dc
skin
vaccin
site
drain
ln
immunofluoresc
microscopi
reveal
gfp
transgen
express
skin
dc
even
though
specif
character
transgen
express
cell
undertaken
present
studi
specul
base
previou
observ
local
morpholog
featur
larg
portion
transgeneexpress
cell
fibroblast
find
indic
direct
transduct
dc
requir
inject
vector
elicit
cell
respons
like
achiev
crosspresent
epitop
dc
line
previous
report
influenza
nucleoproteinspecif
cell
respons
mice
also
depend
crossprim
inde
found
transgen
epitop
readili
crosspres
dc
upon
coincub
allogen
mhc
missmatch
transduc
fibroblast
vitro
although
find
demonstr
high
efficaci
vaccin
without
direct
dc
infect
may
strictli
inher
use
vector
encod
defin
cell
epitop
fuse
foreign
egfp
helper
cell
epitop
rather
fulllength
self
protein
could
facilit
rapid
highli
effici
dissemin
epitop
surround
bystand
cell
includ
apc
subsequ
highefficaci
crosspresent
inde
id
vaccin
vector
encod
fulllength
could
induc
protect
antimelanoma
immun
find
data
shown
thu
efficaci
id
vaccin
vector
encod
fulllength
tumor
antigen
target
vivo
deliveri
transgen
dc
may
warrant
current
investig
issu
skinderiv
dc
thought
key
player
initi
cell
immun
upon
viral
infect
skin
studi
lentivir
vector
inde
demonstr
direct
role
skin
dc
induct
cell
respons
studi
hsv
shown
skin
dc
littl
direct
involv
cell
prime
elucid
issu
vaccin
remov
skin
vaccin
site
id
inject
even
though
skin
dc
subsetspecif
involv
antigenspecif
cell
prime
evalu
present
studi
ie
lc
vs
dermal
dc
subset
base
report
lc
dermal
dc
take
longer
reach
drain
ln
conclud
like
dc
skindrain
ln
skinderiv
dc
dominantli
involv
cross
present
vector
deliv
antigen
cell
skin
drain
ln
subsequ
induct
protect
antitumor
immun
dc
would
obviou
candid
subset
regard
unlik
previou
report
abrog
herp
simplex
viru
plasmid
dna
encod
ova
induc
cell
respons
upon
scarif
immun
site
excis
immun
site
within
hour
postvaccin
id
complet
abrog
immun
respons
importantli
effect
protect
subsequ
tumor
outgrowth
whether
observ
reduct
specif
cell
respons
immun
siteexcis
group
either
due
overal
reduct
antigen
load
due
remov
antigenexpos
skin
dc
requir
investig
role
tlr
signal
viral
vectorinduc
innat
adapt
immun
respons
studi
use
defici
mice
contradictori
report
abil
defici
mice
mount
proinflammatori
innat
immun
respons
infect
interestingli
defect
matur
dc
defici
mice
upon
exposur
vaccinia
viru
report
inde
recent
report
suggest
activ
murin
dc
vitro
may
tlrdepend
independ
found
critic
protect
antitumor
immun
vivo
line
previou
find
role
ctl
reactiv
carcinoembryon
antigen
vaccinia
viru
vacv
induc
vacvspecif
effector
cell
respons
observ
hamper
antimelanoma
immun
vaccin
ko
mice
appear
due
impair
antigen
cross
present
capac
dc
defici
dc
matur
normal
data
shown
also
abl
stimul
induc
product
ctl
follow
infect
cocultur
infect
fibroblast
vitro
besid
dc
non
immun
cell
also
found
express
signal
eg
macrophag
cell
elimin
local
macrophag
id
inject
liposomecomplex
clodron
prior
id
vaccin
hand
interfer
vaccin
efficaci
data
shown
exclud
possibl
role
macrophag
observ
induct
protect
cellmedi
antitumor
immun
recent
studi
demonstr
cellexpress
play
import
intrins
role
lymphocyt
choriomening
vaccinia
viru
induc
specif
cell
surviv
accumul
clonal
expans
tempt
specul
transgen
specif
cell
may
similarli
depend
mediat
signal
process
clonal
expans
surviv
altern
tlr
express
assessori
cell
vivo
eg
fibroblast
may
led
signal
cytokin
releas
upon
infect
turn
may
activ
neighbour
dc
studi
need
clarifi
precis
mechan
underli
observ
depend
summari
id
vaccin
tumor
vaccin
found
optim
deliveri
rout
induct
system
antigen
specif
cell
respons
abl
prevent
establish
sc
lung
tumor
administ
directli
infect
transduc
dc
rather
infect
fibroblastlik
cell
subsequ
induct
protect
cellmedi
antitumor
immun
like
depend
crosspresent
antigen
dc
drain
ln
involv
signal
adaptor
protein
dc
level
present
find
suggest
rout
administr
also
anatom
locat
tumor
taken
consider
vaccin
design
evalu
intraderm
id
rout
administr
induc
superior
ie
strong
longlast
cell
reactiv
compar
intraven
iv
intranas
intraperiton
ip
administr
produc
cell
peripher
blood
leukocyt
pbl
splenocyt
harvest
day
postvaccin
respect
detect
flow
cytometr
analysi
vitro
stimul
peptid
b
specif
cell
frequenc
also
determin
use
tetram
tm
splenocyt
harvest
day
post
vaccin
present
data
mean
sem
c
mous
local
coat
depigment
vaccin
site
well
site
sc
tumor
inocul
data
analyz
anova
varianc
compar
bonferroni
test
differ
group
consid
signific
p
p
intraderm
id
rout
administr
iumic
protect
mice
subcutan
sc
growth
well
lung
metastasi
melanoma
cell
contrast
intraven
iv
intranas
intraperiton
ip
rout
vaccin
kinet
sc
growth
melanoma
cell
mice
prophylact
vaccin
control
viru
boost
via
id
iv
ip
rout
plot
line
repres
tumor
growth
kinet
individu
mous
indic
number
tumor
bear
micetot
number
mice
b
number
macroscop
visibl
metastas
surfac
lung
mice
vaccin
plot
valu
repres
individu
mous
c
produc
cell
peripher
blood
leukocyt
harvest
day
postvaccin
anim
test
outgrowth
lung
metastas
detect
flow
cytometr
analysi
vitro
stimul
peptid
data
analyz
anova
varianc
compar
bonferroni
test
differ
group
consid
signific
p
p
intraderm
administr
id
predominantli
lead
transduct
nondendrit
cell
dc
skin
dc
dispens
induct
effect
antitumor
respons
mice
inject
either
pb
iu
mice
via
id
administr
flank
skin
skin
site
inject
pb
respect
inject
site
drain
lymph
node
ln
axillari
harvest
analyz
immunofluoresc
stain
viru
transduc
cell
detect
transgen
gfp
green
express
dendrit
cell
skin
detect
use
antiia
ie
antibodi
red
ln
dc
antibodi
red
cell
nuclei
detect
use
dapi
blue
magnif
data
shown
repres
three
independ
experi
experiment
group
consist
two
three
mice
b
mice
id
vaccin
iumic
flank
skin
vaccin
site
surgic
excis
rate
produc
cell
peripher
blood
leukocyt
post
vaccin
splenocyt
post
vaccin
determin
flow
cytometr
analysi
vitro
restimul
peptid
mean
sem
plot
data
analyz
anova
varianc
compar
bonferroni
test
differ
group
consid
signific
p
p
c
kinet
sc
growth
melanoma
cell
mice
prophylact
vaccin
via
id
rout
control
similarli
vaccin
mice
vaccin
site
surgic
excis
plot
line
repres
tumor
growth
kinet
individu
mous
indic
number
tumor
bear
micetot
number
mice
specif
cell
respons
induc
intraderm
administr
depend
adapt
protein
dendrit
cell
dc
level
cell
rate
determin
peripher
blood
leukocyt
pbl
splenocyt
harvest
wild
type
wt
ko
mice
day
postvaccin
respect
cell
determin
flow
cytometr
analysi
vitro
restimul
peptid
mean
sem
plot
data
analyz
anova
varianc
compar
bonferroni
test
differ
group
consid
signific
p
b
kinet
sc
growth
melanoma
cell
